About Danesh Pharmaceutical Development Company (شرکت توسعه داروسازی دانش)

Danesh Pharmaceutical Development Company produces the strategic drug Danloyn (Fingolimod) from the initial stages of active ingredient production to final formulation as 0.5 mg capsules, in collaboration with Nanoalvand Pharmaceutical Company, relying on the technical knowledge of domestic expert personnel.

Vision

Our vision is to become a successful pharmaceutical company in improving community health and to be recognized as a pharmaceutical company through innovation and production of quality products. The company aims to strengthen its presence in society by producing rare drugs at reasonable prices and high quality, complying with global standards.

Services (3)

• Bosentan (Active Pharmaceutical Ingredient)
• Fingolimod (Active Pharmaceutical Ingredient)
• Active Pharmaceutical Ingredients for Special Diseases